Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Tranexamic Acid

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    82 result(s) found for: Tranexamic Acid. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2006-004561-34 Sponsor Protocol Number: 4.2006.1285 Start Date*: 2006-11-16
    Sponsor Name:St. Olavs Hospital
    Full Title: Tranexamic acid to elderly patients undergoing combined AVR and CABG surgery.
    Medical condition: We will investigate whether tranexamic acid given as a bolus injection at the start of surgery followed by a continuous infusion during surgery reduces postoperative bleeding in patients above 70 y...
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: NO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-000898-23 Sponsor Protocol Number: 2019/KEP/218 Start Date*: 2019-08-01
    Sponsor Name:London School of Hygiene and Tropical Medicine
    Full Title: Pharmacokinetics of intramuscular tranexamic acid in trauma patients: a clinical trial
    Medical condition: Traumatic haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10053476 Traumatic haemorrhage PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-002480-17 Sponsor Protocol Number: FPS-TRA-2017-02 Start Date*: 2017-11-13
    Sponsor Name:Fundación Pública Andaluza Progreso y Salud
    Full Title: Randomized, placebo-controlled, double-blind trial to evaluate the efficacy and safety of topical application of tranexamic acid for saving blood losses in patients subjected to prosthetic knee su...
    Medical condition: Knee arthrosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-004167-29 Sponsor Protocol Number: NA Start Date*: 2021-03-15
    Sponsor Name:CHU de Liège
    Full Title: Study of the noninferiority of an oral versus intravenous administration of tranexamic acid in total hip arthroplasty
    Medical condition: Bleeding in total hip arthroplasty
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-000071-24 Sponsor Protocol Number: TRANEXTIME Start Date*: 2016-03-10
    Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR)
    Full Title: TIME OF ADMINISTRATION OF TRANEXAMIC ACID TO PREVENT BLEEDING IN TOTAL KNEE ARTHROPLASTY
    Medical condition: Total knee arthroplasty bleeding
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-002661-36 Sponsor Protocol Number: 15039DB-SW Start Date*: 2016-03-10
    Sponsor Name:Belfast Health and Social Care Trust
    Full Title: Single centre randomised controlled trial to assess the effect of the addition of twenty-four hours of oral tranexamic acid post-operatively to a single intra-operative intravenous dose of tranexam...
    Medical condition: Osteoarthritic patients who require hip or knee arthroplasty
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-005473-52 Sponsor Protocol Number: 40964 Start Date*: 2014-04-24
    Sponsor Name:Hospital of South West Jutland
    Full Title: Prevention of bleeding and edema in bi-maxillary orthognathic surgery; the effectiveness of tranexamic acid on intraoperative bleeding in orthognathic surgery
    Medical condition: Surgical bleeding during bi-maxillary orthognathic surgery
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004863 10051536 Intraoperative bleeding LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2021-001381-38 Sponsor Protocol Number: 1 Start Date*: 2021-08-30
    Sponsor Name:Plastikkirurgisk og brystkirurgisk afdeling, Region Sjælland
    Full Title: Topical use of tranexamic acid for optimisation of wound healing in a novel, acute wound model
    Medical condition: Immunomodulation of postoperative inflammatory reactions and thereby reduction of wound fluid production and improved healing by topical administration of tranexamic acid.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10002784 Antifibrinolysis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-005592-12 Sponsor Protocol Number: 76873 Start Date*: 2021-08-30
    Sponsor Name:Plastikkirurgisk og brystkirurgisk afdeling, Region Sjælland
    Full Title: The effect of tranexamic acid on seroma formation after mastectomies
    Medical condition: Immunomodulation of postoperative inflammatory reactions and thereby reduction of wound seroma by topical administration of tranexamic acid.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10002784 Antifibrinolysis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001299-19 Sponsor Protocol Number: GJNH-06-01 Start Date*: 2006-05-12
    Sponsor Name:Golden Jubilee National Hospital
    Full Title: Prospective randomised trial comparing intraoperative topical Quixil and intravenous tranexamic acid in reduction of blood loss following primary hip and knee joint replacement surgery
    Medical condition: Elective total knee replacement and total hip replacement.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004320-11 Sponsor Protocol Number: 222013 Start Date*: 2014-05-07
    Sponsor Name:CARLOS SANTOS VILLAR
    Full Title: A ONE YEAR STUDY ON THE USE OF TRANEXAMIC ACID IN BENIGN PROSTATIC HYPERPLASIA SURGERY
    Medical condition: BENIGN PROSTATIC HYPERTROPHY
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022009-16 Sponsor Protocol Number: 1.0 Start Date*: 2010-11-01
    Sponsor Name:University of Nottingham
    Full Title: A randomised controlled trial of Tranexamic acid in Intracerebral Haemorrhage (TICH)
    Medical condition: Primary intracerebral haemorrhage
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-001513-35 Sponsor Protocol Number: Start Date*: 2016-08-23
    Sponsor Name:NHS Blood and Transplant. [...]
    1. NHS Blood and Transplant.
    2. NHS Blood and Transplant
    Full Title: TREATT: TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia A double blind, randomised controlled trial evaluating the safety and efficacy of Tranexamic acid in patients with haematologic...
    Medical condition: Bleeding secondary to thrombocytopaenia associated to haematological malignancies.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004866 10005103 Bleeding LLT
    20.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10066476 Haematological malignancy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2022-003163-21 Sponsor Protocol Number: COTHUGMTRA22 Start Date*: 2023-07-13
    Sponsor Name:Coral Sánchez Pérez
    Full Title: PHASE III, SINGLE-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, LOW-INTERVENTION CLINICAL TRIAL IN TWO PARALLEL GROUPS, TO EVALUATE EFFICACY AND SAFETY IN ELDERLY PATIENTS WITH PERTROCHANTE...
    Medical condition: pertrochanteric hip fracture
    Disease: Version SOC Term Classification Code Term Level
    23.0 10022117 - Injury, poisoning and procedural complications 10020100 Hip fracture PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-002118-37 Sponsor Protocol Number: HTAJ-TRANEX-2019-01 Start Date*: 2021-06-17
    Sponsor Name:Rafael Blancas-Gómez Casero
    Full Title: MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS
    Medical condition: Pacemaker implant for anticoagulated patients
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-003537-15 Sponsor Protocol Number: TXA2018 Start Date*: 2019-02-18
    Sponsor Name:Medical University Vienna
    Full Title: Different dosing of Tranexamic Acid in patients undergoing elective total hip or knee arthroplasty. A randomized, controlled, double-blinded clinical trial.
    Medical condition: Blood loss in patients undergoing elective total hip or knee arthroplasty.
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004863 10053220 Hip injury LLT
    20.1 100000004863 10049032 Knee injury LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-003321-32 Sponsor Protocol Number: 108 Start Date*: 2021-01-21
    Sponsor Name:Hvidovre Hospital, Dep. of Orthopaedic Surgery
    Full Title: Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty
    Medical condition: The benefit of additional Tranexamic Acid (TXA) injected intra-articular at the end of surgery for patients undergoing a unilateral total hip arthroplasty in addition to conventional IV TXA to redu...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10003397 Arthroplasty of hip LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-005103-41 Sponsor Protocol Number: 8200 Start Date*: 2005-12-05
    Sponsor Name:Anne Mette Hvas
    Full Title: Clot formation and clot stability in severe haemophilia A - effect of recombinant factor VIII and tranexamic acid.
    Medical condition: Severe haemophilia A
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-001426-17 Sponsor Protocol Number: 1M Start Date*: 2018-01-03
    Sponsor Name:University Hospitals Leuven (Gasthuisberg)
    Full Title: Tranexamic Acid to reduce bleeding in patients treated with new oral anticoagulants undergoing dental extraction (EXTRACT-NOAC)
    Medical condition: Patients treated with a NOAC, aged 18 years or older undergoing dental extraction
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2018-000910-39 Sponsor Protocol Number: BRTR1 Start Date*: 2018-12-13
    Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE
    Full Title: Efficacy of tranexamic acid in reducing post-operative bleeding in oncologic-reconstructive breast surgery
    Medical condition: Post-operative hematoma
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10064765 Breast hematoma LLT
    20.0 100000004863 10018857 Haematoma postoperative LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 01:31:28 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA